GNTA — Genenta Science SpA Share News
0.000.00%
Last trade - 00:00Brief: Genenta Science SpA -Entered Amendment To ATM Sales Agreement Dated April 26
Brief: Genenta To Provide Update On Lead Product Temferon™
Genenta Science rises on FDA's "orphan drug" tag for brain cancer drug
Brief: FDA Grants Orphan Drug Designation To Brain Cancer Treatment
Brief: Genenta Science And Agc Biologics Enter Development And Manufacturing Service Agreement
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:10 AM
NASDAQ RESUMED AT 10:10 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
NASDAQ RESUMED AT 03:47 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:42 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:00 AM
NASDAQ RESUMED AT 09:54 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
Italy's Genenta Science falls in Nasdaq debut
NASDAQ RESUMED AT 11:35 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM